285 related articles for article (PubMed ID: 17434559)
41. Minichromosome Maintenance Proteins Cooperate with LANA during the G
Dabral P; Uppal T; Rossetto CC; Verma SC
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
[TBL] [Abstract][Full Text] [Related]
42. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
43. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
Kedes DH; Lagunoff M; Renne R; Ganem D
J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
[TBL] [Abstract][Full Text] [Related]
44. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.
Verma SC; Borah S; Robertson ES
J Virol; 2004 Oct; 78(19):10348-59. PubMed ID: 15367601
[TBL] [Abstract][Full Text] [Related]
45. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
46. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
[TBL] [Abstract][Full Text] [Related]
47.
Pires de Miranda M; Quendera AP; McVey CE; Kaye KM; Simas JP
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111565
[TBL] [Abstract][Full Text] [Related]
48. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
49. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
[TBL] [Abstract][Full Text] [Related]
50. LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes.
Dabral P; Babu J; Zareie A; Verma SC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723020
[TBL] [Abstract][Full Text] [Related]
51. H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.
Jha HC; Upadhyay SK; A J Prasad M; Lu J; Cai Q; Saha A; Robertson ES
J Virol; 2013 May; 87(9):5255-69. PubMed ID: 23449797
[TBL] [Abstract][Full Text] [Related]
52. Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.
Campbell M; Chang PC; Huerta S; Izumiya C; Davis R; Tepper CG; Kim KY; Shevchenko B; Wang DH; Jung JU; Luciw PA; Kung HJ; Izumiya Y
J Biol Chem; 2012 Feb; 287(8):5806-18. PubMed ID: 22179613
[TBL] [Abstract][Full Text] [Related]
53. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
[TBL] [Abstract][Full Text] [Related]
54. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
55. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
[TBL] [Abstract][Full Text] [Related]
56. Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region.
Su L; Liao Q; Wu Y; Chen X
PLoS One; 2011 Apr; 6(4):e19106. PubMed ID: 21544244
[TBL] [Abstract][Full Text] [Related]
57. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest.
An FQ; Compitello N; Horwitz E; Sramkoski M; Knudsen ES; Renne R
J Biol Chem; 2005 Feb; 280(5):3862-74. PubMed ID: 15525642
[TBL] [Abstract][Full Text] [Related]
58. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
Paudel N; Sadagopan S; Balasubramanian S; Chandran B
J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
[TBL] [Abstract][Full Text] [Related]
59. Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.
Jin Y; He Z; Liang D; Zhang Q; Zhang H; Deng Q; Robertson ES; Lan K
J Virol; 2012 May; 86(9):4956-69. PubMed ID: 22379075
[TBL] [Abstract][Full Text] [Related]
60. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
Fujimuro M; Wu FY; ApRhys C; Kajumbula H; Young DB; Hayward GS; Hayward SD
Nat Med; 2003 Mar; 9(3):300-6. PubMed ID: 12592400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]